Edwards Lifesciences (EW)

Edwards Lifesciences Stock Price & Analysis


EW Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$67.13 - $131.73
Previous Close$77.56
Average Volume (3M)4.47M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.74B
Total Debt (Recent Filing)$686.80M
Price to Earnings (P/E)33.4
Next EarningsFeb 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)2.32
Shares Outstanding618,260,499
Standard Deviation0.09
10 Day Avg. Volume4,352,867
30 Day Avg. Volume4,471,494
Price to Book (P/B)9.97
Price to Sales (P/S)8.94
Price to Cash Flow (P/CF)37.10
P/FCF Ratio46.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside20.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering22


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Edwards Lifesciences’s price range in the past 12 months?
Edwards Lifesciences lowest stock price was $67.13 and its highest was $131.73 in the past 12 months.
    What is Edwards Lifesciences’s market cap?
    Currently, no data Available
    When is Edwards Lifesciences’s upcoming earnings report date?
    Edwards Lifesciences’s upcoming earnings report date is Feb 02, 2023 which is in 61 days.
      How were Edwards Lifesciences’s earnings last quarter?
      Edwards Lifesciences released its earnings results on Oct 27, 2022. The company reported $0.61 earnings per share for the quarter, missing the consensus estimate of $0.621 by -$0.011.
        Is Edwards Lifesciences overvalued?
        According to Wall Street analysts Edwards Lifesciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Edwards Lifesciences pay dividends?
          Edwards Lifesciences does not currently pay dividends.
          What is Edwards Lifesciences’s EPS estimate?
          Edwards Lifesciences’s EPS estimate is $0.61.
            How many shares outstanding does Edwards Lifesciences have?
            Edwards Lifesciences has 618,260,500 shares outstanding.
              What happened to Edwards Lifesciences’s price movement after its last earnings report?
              Edwards Lifesciences reported an EPS of $0.61 in its last earnings report, missing expectations of $0.621. Following the earnings report the stock price went down -17.879%.
                Which hedge fund is a major shareholder of Edwards Lifesciences?
                Among the largest hedge funds holding Edwards Lifesciences’s share is Sands Capital Management LLC. It holds Edwards Lifesciences’s shares valued at 860M.


                  Edwards Lifesciences Stock Smart Score

                  The Edwards Lifesciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Edwards Lifesciences

                  Incorporated in 1958, California-based Edwards Lifesciences Corp. is a medical technology company, which specializes in structural heart disease and critical care and surgical monitoring. It reports in three segments: Transcatheter Aortic Valve Replacements, Transcatheter Mitral and Tricuspid Therapies and Surgical Structural Heart and Critical Care.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Abbott Labs
                  Intuitive Surgical
                  Becton Dickinson
                  Boston Scientific

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis